In this issue:
FLAMES: PFS benefit to front-line senaparib maintenance
NORA finds favourable OS with niraparib maintenance in PSROC
anti-PD-1-mediated reinvigoration potential of CD8+ TILs in BRCA wild-type EOC
Std KELIM validated as a prognostic marker of chemosensitivity in EOC
The BLOODS score estimates risk of blood transfusion during debulking surgery
Incidence of VTE during neoadjuvant chemotherapy
Favourable prognosis in endometriosis-associated ovarian cancer
Primary vs interval surgery for BRCA-mutated high-grade serous disease
Robotic interval debulking surgery feasible for advanced ovarian cancer
Secondary cytoreduction remains beneficial for PSROC
Please login below to download this issue (PDF)